Edition:
India

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

10.93USD
8:55pm IST
Change (% chg)

$-0.22 (-1.97%)
Prev Close
$11.15
Open
$11.05
Day's High
$11.13
Day's Low
$10.86
Volume
7,572
Avg. Vol
40,506
52-wk High
$17.76
52-wk Low
$10.40

Chart for

About

Cue Biopharma Inc is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

BRIEF-Peter Appel Reports Passive Stake Of 7.6 Pct In Cue Biopharma

* PETER APPEL REPORTS A PASSIVE STAKE OF 7.6 PERCENT IN CUE BIOPHARMA INC AS OF DEC 27, 2017 - SEC FILING Source text: (http://bit.ly/2BWquxU) Further company coverage:

13 Feb 2018

Earnings vs. Estimates

No consensus analysis data available.